CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 252 enrolled
Drug / intervention
Standard transrectal 12 core biopsy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03859804
NCT03859804N/ACompleted

Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy

TC Erciyes University·interventional·Posted Mar 1, 2019·Updated Mar 1, 2019

In Brief

A clinical study evaluating Standard transrectal 12 core biopsy and MRI- US fusion prostate biopsy (FPB) for Pain Due to Certain Specified Procedures and 2 related conditions. Completed, enrolled 252 participants across 1 site.

Detailed Summary

The aim of this study was to compare the pain levels in transrectal ultrasound (TRUS)-guided standard 12-core prostate biopsy (SPB) and multiparametric prostate magnetic resonance imaging (MpMRI)-guided fusion prostate biopsy (FPB).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 1, 2019
Enrollment StartDec 1, 2016
Primary CompletionJan 31, 2019
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.3 years ago

Interventions

Standard transrectal 12 core biopsyprocedure

TRUS-guided SPB was performed by obtaining 12 core samples in each patient. 6 cores from left and right. the cores labeled as, apex, mid, base, apex far lateral, mid far lateral and base far lateral

MRI- US fusion prostate biopsy (FPB)procedure

FPB was performed by obtaining 10-12 core samples in each patient, followed by the acquisition of 2-4 core samples for each suspected lesion detected on MpMRI (combined biopsy)